Centessa Pharmaceuticals-adr Earnings

Centessa Pharmaceuticals-adr’s revenue fell -100% since last year same period to $0Mn in the Q4 2025. On a quarterly growth basis, Centessa Pharmaceuticals-adr has generated NaN% jump in its revenue since last 3-months.

Centessa Pharmaceuticals-adr’s net profit jumped 40.57% since last year same period to $-66.16Mn in the Q4 2025. On a quarterly growth basis, Centessa Pharmaceuticals-adr has generated -20.54% fall in its net profits since last 3-months.

Centessa Pharmaceuticals-adr’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2025. On a quarterly growth basis, Centessa Pharmaceuticals-adr has generated NaN% jump in its net profit margins since last 3-months.

Centessa Pharmaceuticals-adr’s earning per share (EPS) estimates for the current quarter stand at -0.38 - a 0.13% jump from last quarter’s estimates.

Centessa Pharmaceuticals-adr’s earning per share (EPS) estimates for the current year stand at -0.38.

Centessa Pharmaceuticals-adr’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Centessa Pharmaceuticals-adr has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.